First experience with endovascular recanalization of chronic internal carotid artery occlusion

A E Petrov1, N Yu Tukanov1, V V Bobinov1

  • 1Polenov Russian Scientific Research Institute of Neurosurgery - Branch of FSBI 'Almazov National Medical Research Centre' of the Ministry of Health Care of Russian Federation, 191014, Saint-Petersburg, Russian Federation.

Insights

Endovascular recanalization successfully restored internal carotid artery (ICA) lumen in 66.6% of patients with chronic occlusion, significantly reducing risks of recurrent ischemic events. This promising method offers effective restoration of brain perfusion.

Area of Science:

  • Vascular Neurosurgery
  • Endovascular Therapy
  • Cerebrovascular Disease

Background:

  • Atherosclerotic lesions affect 20-50% of the population, with chronic internal carotid artery (ICA) occlusion posing a significant stroke risk.
  • Ischemic stroke develops in 6-15% of patients with chronic ICA occlusion, and annual risks of acute ischemic disorders range from 6-20% despite treatment.

Purpose of the Study:

  • To evaluate the efficacy and safety of endovascular recanalization for chronic internal carotid artery (ICA) occlusion.

Main Methods:

  • Analysis of intravascular treatment outcomes in 12 patients (average age 57) with chronic ICA occlusion.
  • Classification of occlusion types using the D. Hasan scale (2018).
  • Assessment of technical success, restenosis, and recurrent ischemic events through imaging and follow-up.

Main Results:

  • Successful ICA lumen restoration achieved in 8 (66.6%) out of 12 patients.
  • No restenosis or recurrent ischemic events observed in 6 patients with successful recanalization.
  • Technical success was not achieved in 4 patients, primarily those with Type D occlusions or severe scarring.

Conclusions:

  • Endovascular recanalization is a promising and effective method for restoring chronic ICA occlusion.
  • The procedure can normalize brain perfusion and reduce the risk of recurrent ischemic cerebral events.
  • Challenges remain for specific occlusion types (e.g., Type D) and severely scarred arteries.
Abstract